BCL2L1 and acute lymphoblastic leukemia: Although ALL-SIL displayed a low BCL2/BCL2L1 ratio (Supplementary Figure S2A), as opposed to LOUCY and MOLT-16, it was also highly sensitive (Figure 2A,B).